Can anti-osteoporosis drugs be selected based on bone turnover markers?
ZHANG Zhen-lin
Abstract：Choosing appropriate anti-osteoporosis drugs can reduce the risk of fractures and achieve treatment goals.This article focuses on a hot topic in our clinical practice,whether clinical physicians can choose bone resorption inhibitors or bone formation promoters on the level of bone turnover biochemical markers in the management of primary osteoporosis?This article provides a review on important guidelines or relevant research results at home and abroad.
Keywords：osteoporosisbone turnover markersdrug selection
Publication Date：2025-08-01
Online Publishing Date：2025-10-09(First online date of this platform, not the publication date of the document)
Pages：4( 629-632 )